Accessibility Menu
 
Exelixis logo

Exelixis

(NASDAQ) EXEL

Current Price$49.45
Market Cap$12.49B
Since IPO (2000)+227%
5 Year+98%
1 Year+37%
1 Month+12%

Exelixis Financials at a Glance

Market Cap

$12.49B

Revenue (TTM)

$2.38B

Net Income (TTM)

$833.42M

EPS (TTM)

$3.02

P/E Ratio

16.48

Dividend

$0.00

Beta (Volatility)

0.62 (Low)

Price

$49.45

Volume

196,168

Open

$50.11

Previous Close

$49.45

Daily Range

$48.83 - $50.11

52-Week Range

$33.76 - $50.48

EXEL: Motley Fool Moneyball Superscore

83

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Exelixis

Industry

Biotechnology

Employees

1,077

CEO

Michael M. Morrissey, PhD

Headquarters

Alameda, CA 94502, US

EXEL Financials

Key Financial Metrics (TTM)

Gross Margin

96%

Operating Margin

39%

Net Income Margin

35%

Return on Equity

41%

Return on Capital

42%

Return on Assets

32%

Earnings Yield

6.07%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.49B

Shares Outstanding

251.35M

Volume

196.17K

Avg. Volume

2.82M

Financials (TTM)

Gross Profit

$2.24B

Operating Income

$872.19M

EBITDA

$921.76M

Operating Cash Flow

$884.27M

Capital Expenditure

$39.93M

Free Cash Flow

$844.34M

Cash & ST Invst.

$1.06B

Total Debt

$173.04M

Exelixis Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$610.81M

+10.0%

Gross Profit

$590.86M

+10.2%

Gross Margin

96.73%

N/A

Market Cap

$12.49B

N/A

Market Cap/Employee

$10.89M

N/A

Employees

1,147

N/A

Net Income

$210.47M

+31.9%

EBITDA

$258.29M

+33.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$607.67M

-28.0%

Accounts Receivable

$328.95M

+16.8%

Inventory

$26.61M

+7.0%

Long Term Debt

$169.54M

-9.4%

Short Term Debt

$0.00

N/A

Return on Assets

32.13%

N/A

Return on Invested Capital

42.14%

N/A

Free Cash Flow

$249.81M

+32.2%

Operating Cash Flow

$251.84M

+19.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BBIOBridgeBio Pharma, Inc.
$65.95+1.96%
ALGNAlign Technology, Inc.
$165.79+0.72%
MDGLMadrigal Pharmaceuticals, Inc.
$510.26+2.66%
BMRNBioMarin Pharmaceutical Inc.
$52.88+0.57%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$120.61-0.07%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$15.96-0.05%
NOKNokia
$13.17-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$74.96-0.03%

Questions About EXEL

What is the current price of Exelixis?

Exelixis is trading at $49.45 per share.

What is the 52-week range for Exelixis?

Over the past 52 weeks, Exelixis has traded between $33.76 and $50.48.

How much debt does Exelixis have?

As of the most recent reporting period, Exelixis reported total debt of $169.54M.

How much cash does Exelixis have on hand?

Exelixis reported $163.44M in cash and cash equivalents in its most recent financial results.

What is Exelixis’s dividend yield?

Exelixis does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.